Trial intelligence / Profile preview

Dexamethasone versus ondansetron for prevention of post-endoscopy nausea, vomiting, and delirium in children

IRCT20200809048343N1Phase 3Completed

Sponsor
Kashan University of Medical Sciences
Start
Aug 2020
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 3, randomised, single-blind trial of dexamethasone and ondansetron in postoperative nausea and vomiting (PONV) and Emergence agitation (EA) (3 arms), sponsored by Kashan University of Medical Sciences. Primary endpoints: Postoperative nausea and vomiting and Delirium. Started Aug 2020; status: completed.

02

Drugs

dexamethasoneondansetron
03

Conditions

postoperative nausea and vomiting (PONV)Emergence agitation (EA)

Beyond the preview

Go deeper on IRCT20200809048343N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20200809048343N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call